TAK-861, TAK-861 placebo (same excipients as TAK-861), TAK-861 clinical trials

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy (Narcolepsy Type 1)

This study is testing a new medicine, TAK-861, for people with narcolepsy and cataplexy. Researchers want to see if it helps reduce sleepiness and cataplexy attacks, and if it's safe to use. It's a key step before the medicine could become widely available.